Medical Devices & Consumables / Neurostimulation Devices Market - Global Growth, Trends And Forecast (2022 - 2027) By Types, By Application, By Regions And By Key Players: Abbott, Boston Scientific Corporation, IntraPace, Laborie
Neurostimulation Devices Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Abbott, Boston Scientific Corporation, IntraPace, Laborie
The global Neurostimulation Devices market is estimated to grow at 10.6% CAGR during the forecast period (2022-2027).
Neurostimulation Devices Market Overview
Technological advancements and increased demand for improved neurostimulation devices to better patient outcomes will drive market expansion. The increased prevalence of a variety of health conditions such as epilepsy, depression, Parkinson's disease, migraine, and others is fueling demand for various neurostimulation devices. Furthermore, a favorable regulatory environment for medical modalities that provide greater patient care and management will aid market growth. Neurostimulation devices are predicted to bring treatment to an unprecedented number of individuals suffering from serious neurologic and psychiatric problems as technology advances. The sector is expected to increase due to the availability of implantable neurostimulation devices that target specific cranial, spinal, and peripheral nerve regions to regulate neuronal activity and provide therapeutic effects for a variety of neurological illnesses.
The report aspects discussed the profile of the top manufacturers of the global Neurostimulation Devices market. These aspects include financial status of major companies, trending advancements and entire market scenario. Growth of the report have examined Neurostimulation Devices Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.
Neurostimulation Devices Market Growth Derivers
Increasing demand for minimally invasive surgery in developed countries
Increasing prevalence of neurological disorders globally
Technological advancements in neurostimulation devices
Increasing number of elderly patients with neurological disorders
Industry News and Updates:
ABBOTT TO LAUNCH THE NEUROSPHERE™ MYPATH™ DIGITAL HEALTH APP DESIGNED TO TRACK AND REPORT PAIN RELIEF IN CHRONIC PAIN PATIENTS WITH PHYSICIANS PRIOR TO DEVICE IMPLANT-- Top of Form
Abbott (NYSE: ABT) today announced the upcoming launch of NeuroSphere™ myPath™, a digital health app designed to track and report on patient perceived pain relief and general well-being associated with spinal cord stimulation (SCS) or dorsal root ganglion (DRG) therapy. During the device trial period required before the permanent implant, the app allows patients to record their outcomes on pain and well-being while trialing their neurostimulation therapy.
June 10, 2021: Medtronic Announces FDA Approval of its Next Generation Recharge-Free Spinal Cord Stimulation Platform--
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for Vanta™, a high performance recharge-free implantable neurostimulator (INS) with a device life that can be optimized up to 11 years. At comparable settings, the Vanta neurostimulator offers nearly twice the device life than competitive primary cell devices.1,2 It also utilizes Medtronic's proprietary AdaptiveStim™ technology for personalized pain relief that adapts to the patient's movement or body position using a built-in accelerometer.
What are the major Applications, Types and Regions for Neurostimulation Devices Market?
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Other
By Application, it is segmented into
Pain Management
Parkinson’s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Other
Neurostimulation Devices Market Regional Analysis
The market for neurostimulation devices in North America was worth more than USD 3.8 billion in 2020, thanks to the rising frequency of neurological illnesses in the region. According to a report from the Centers for Disease Control and Prevention (CDC), the burden of Alzheimer's disease and associated dementias (ADRD) in the United States will double by 2060. The growth in ADRD cases is due to a growing geriatric population and an unhealthy lifestyle. Increasing R&D and the adoption of minimally invasive procedures, as well as the creation of technologically advanced neurostimulation devices, are all elements that are promoting regional growth.
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
Middle East & Africa
Latin America
The Neurostimulation Devices Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Neurostimulation Devices Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
What is our Neurostimulation Devices Market report scope?
Report Attributes
Report Details
Forecast Period 2022 to 2027 CAGR
CAGR of 10.6% over the forecast period (2022-2027)
By Type
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Other
By Application
Pain Management
Parkinson’s Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Other
By Companies
Abbott, Boston Scientific Corporation, IntraPace, Laborie, LivaNova, Medtronic, Neuronetics, SPR Therapeutics, Cyberonics, ElectroCore Inc., Aleva Neurotherapeutics SA, Synapse Biomedical Inc., MicroTransponder, RS Medical and BioControl Medical
Regions Covered
North America
Europe
Asia-Pacific
Rest of the World
Countries Covered
US
Canada
Germany
France
UK
Italy
Spain
Rest of Europe
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
Latin America
Base Year
2022
Historical Year
2017 to 2021
Forecast Year
2022 to 2027
Number of Pages
119
Customization Available
Yes, the report can be customized as per your needs
Frequently Asked Questions
What is the growth rate of Neurostimulation Devices Market?
The Neurostimulation Devices Market is growing at a CAGR of 10.6% over the next 5 years.
Who are the key players in Neurostimulation Devices Market?
Abbott, Boston Scientific Corporation, IntraPace, Laborie, LivaNova, Medtronic, Neuronetics, SPR Therapeutics, Cyberonics, ElectroCore Inc., Aleva Neurotherapeutics SA, Synapse Biomedical Inc., MicroTransponder, RS Medical and BioControl Medical
What are the significant types of Neurostimulation Devices Market?
Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Other
What are the major end-use applications of Neurostimulation Devices Market?
Pain Management, Parkinson’s Disease, Urinary and Fecal Incontinence, Epilepsy, Gastroparesis, Other
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
INTRODUCTION
MARKET DEFINITION
MARKET DYNAMICS
MARKET SEGMENTATION
REPORT TIMELINES
KEY STAKEHOLDERS
RESEARCH METHODOLOGY
DATA MINING
SECONDARY RESEARCH
PRIMARY RESEARCH
SUBJECT MATTER EXPERT ADVICE
QUALITY CHECK
FINAL REVIEW
DATA TRIANGULATION
BOTTOM-UP APPROACH
TOP-DOWN APPROACH
RESEARCH FLOW
EXECUTIVE SUMMARY
INTRODUCTION
GLOBAL NEUROSTIMULATION DEVICES MARKET BY TYPE
GLOBAL NEUROSTIMULATION DEVICES MARKET BY APPLICATION
MARKET DYNAMICS
DRIVERS
INCREASING DEMAND FOR NEUROSTIMULATION DEVICES
RESTRAINTS
STRINGENT ENVIRONMENTAL REGUALTIONS
HIGH COST ON MATERIALS
OPPORTUNITIES
NEUROSTIMULATION DEVICES GROWTH
APPLICATION OF NEUROSTIMULATION DEVICES
IMPACT OF COVID 19
GLOBALNEUROSTIMULATION DEVICESMARKET, BY TYPE
INTRODUCTION
SPINAL CORD STIMULATION (SCS)
GASTRIC ELECTRIC STIMULATION (GES)
DEEP BRAIN STIMULATION (DBS)
SACRAL NERVE STIMULATION (SNS)
VAGUS NERVE STIMULATION (VNS)
OTHER
GLOBAL NEUROSTIMULATION DEVICESMARKET, BY APPLICATION
SECONDARY RESEARCH Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.